Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher

Reuters

8小时前

Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher

Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2586621476"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2586621476\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2586621476?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 15:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2586621476","market":"nz","top_or_hot":-1,"title":"Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSaniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-27 15:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4533","symbol_name":"AQR资本管理(全球第二大对冲基金)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251127:nNDL2ZWX7v:1","article_id":"2586621476","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2586621476","pubTimestamp":1764226851,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Saniona AB reported revenue of SEK 410.7 million for the third quarter  2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC","JAZZ":"爵士制药","IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4532":"文艺复兴科技持仓","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC"},"translate_title":"Saniona AB 2025年第三季度收入飙升至4.107亿瑞典克朗，增长近57倍","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JAZZ":0.9},"content_text":"Saniona AB Q3 2025 revenue surged to SEK 410.7 million, nearly 57 times higher\n    \n\n        Saniona AB reported revenue of SEK 410.7 million for the third quarter (Q3) 2025 and SEK 429.8 million for the nine months ended September 30, 2025. Operating profit reached SEK 359.9 million in Q3 2025, with an operating profit of SEK 317.5 million for the nine-month period. Net profit for Q3 2025 was SEK 329.6 million, while net profit for the nine months ended September 30, 2025 was SEK 326.3 million. Cash and cash equivalents totaled SEK 672.8 million as of September 30, 2025. Basic earnings per share were SEK 2.39 for Q3 2025 and SEK 2.56 for the nine-month period. Diluted earnings per share were SEK 2.35 in Q3 2025 and SEK 2.52 for the nine months ended September 30, 2025. The financial results for the period were positively impacted by an upfront payment from a licensing and partnership agreement with Jazz Pharmaceuticals.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Saniona AB published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}